NCT00148421View on ClinicalTrials.gov

Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy.

PHASE3CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
Anemia
Interventions
DRUG

Darbepoetin alfa and Epoetin alfa

Sponsors

Lead Sponsor

Amgen
All Listed Sponsors
lead

Amgen

INDUSTRY

NCT00148421 - Study for the Treatment of Anemia in Patients With Non-myeloid Malignancies Receiving Multicycle Chemotherapy. | Biotech Hunter | Biotech Hunter